Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [2]
- ELISA [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN393590 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Adducin 1 (Alpha) (ADD1) (AA 1-663) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 1-663
- Isotype
- IgG
- Antibody clone number
- 2C9
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Genetic risk factors for cerebral small-vessel disease in hypertensive patients from a genetically isolated population.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.
Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project.
Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and beta-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes--an 8-year prospective cohort analysis of 1297 patients.
Schuur M, van Swieten JC, Schol-Gelok S, Ikram MA, Vernooij MW, Liu F, Isaacs A, de Boer R, de Koning I, Niessen WJ, Vrooman H, Oostra BA, van der Lugt A, Breteler MM, van Duijn CM
Journal of neurology, neurosurgery, and psychiatry 2011 Jan;82(1):41-4
Journal of neurology, neurosurgery, and psychiatry 2011 Jan;82(1):41-4
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.
Irvin MR, Lynch AI, Kabagambe EK, Tiwari HK, Barzilay JI, Eckfeldt JH, Boerwinkle E, Davis BR, Ford CE, Arnett DK
Journal of hypertension 2010 Oct;28(10):2076-83
Journal of hypertension 2010 Oct;28(10):2076-83
Population based allele frequencies of disease associated polymorphisms in the Personalized Medicine Research Project.
Cross DS, Ivacic LC, Stefanski EL, McCarty CA
BMC genetics 2010 Jun 17;11:51
BMC genetics 2010 Jun 17;11:51
Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and beta-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes--an 8-year prospective cohort analysis of 1297 patients.
Wang Y, Luk AO, Ma RC, So WY, Tam CH, Ng MC, Yang X, Baum L, Lam V, Tong PC, Chan JC
Diabetic medicine : a journal of the British Diabetic Association 2010 Apr;27(4):376-83
Diabetic medicine : a journal of the British Diabetic Association 2010 Apr;27(4):376-83
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- ELISA
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
